Prosecution Insights
Last updated: October 02, 2026
Application No. 19/109,183

NON-INVASIVE BLOOD PRESSURE MEASUREMENT

Non-Final OA §112
Filed
Mar 06, 2025
Priority
Sep 12, 2022 — EU 22195047.0 +1 more
Examiner
SHAH, JAY B
Art Unit
Tech Center
Assignee
Koninklijke Philips N.V.
OA Round
1 (Non-Final)
58%
Grant Probability
Moderate
1-2
OA Rounds
1y 10m
Est. Remaining
64%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
230 granted / 398 resolved
-2.2% vs TC avg
Moderate +6% lift
Without
With
+6.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
44 currently pending
Career history
426
Total Applications
across all art units

Statute-Specific Performance

§101
18.4%
-21.6% vs TC avg
§103
36.3%
-3.7% vs TC avg
§102
12.8%
-27.2% vs TC avg
§112
27.8%
-12.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 398 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-15 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 1, 12 (rest by dependency) recite “clinician-defined”. It is unclear what makes a parameter clinician defined and how a “clinician-defined” parameter is different from any other parameter. Further clarification is requested regarding what parameter “A” is and how it is being determined. Allowable Subject Matter Claims 1-15 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: The closest prior art of record (Muehlsteff – cited by Applicant) teaches determining the frequency with which blood pressure readings are taken based on a risk parameter and a clinician determined risk. However, the prior art fails to teach the exact equation claimed – T ∝ A/pα . None of the prior art considered, alone or in combination, teaches that particular feature combined with the other limitations of the claim. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US 20150157276 A1 – risk-based measurement frequency Any inquiry concerning this communication or earlier communications from the examiner should be directed to JAY B SHAH whose telephone number is (571)272-0686. The examiner can normally be reached M-F 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached at 571-272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. JAY SHAH Primary Examiner Art Unit 3791 /JAY B SHAH/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Mar 06, 2025
Application Filed
Sep 18, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12745950
HYPERHIDROSIS DIAGNOSTIC DEVICE AND METHOD
2y 8m to grant Granted Sep 29, 2026
Patent 12740741
CONDUCTIVE HYDROGEL PAPER-BASED DEVICE FOR SYNCHRONOUSLY MONITORING PHYSIOLOGICAL AND BIOCHEMICAL PARAMETERS
2y 7m to grant Granted Sep 22, 2026
Patent 12738275
Method of Contextual Speech Decoding from the Brain
4y 8m to grant Granted Sep 15, 2026
Patent 12721543
APPARATUS AND METHODS FOR VIRAL AND BACTERIAL BREATH COLLECTION
3y 9m to grant Granted Sep 01, 2026
Patent 12721542
APPARATUS AND METHOD FOR MEASURING END TIDAL CARBON DIOXIDE (ETCO2)
3y 4m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
58%
Grant Probability
64%
With Interview (+6.5%)
3y 5m (~1y 10m remaining)
Median Time to Grant
Low
PTA Risk
Based on 398 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month